Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:59 PM
Ignite Modification Date:
2025-12-24 @ 2:59 PM
NCT ID:
NCT06826859
Eligibility Criteria:
Inclusion Criteria
* Singleton gestation gestational age \<16 0/7 weeks, dating confirmed with ultrasound
* ≥1 high risk factor for preeclampsia or ≥2 moderate risk factors as per United States Preventative Services Task Force (2021)
* Recommendation for 162mg aspirin daily in pregnancy
* Age 16-55 years old
Exclusion criteria
* Contraindication to aspirin
* Current or planned use of any other anticoagulation
* Thrombocytopenia, other known platelet or bleeding disorder
* Abnormally elevated baseline PFA-100 epinephrine closure time prior to aspirin initiation
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
16 Years
Maximum Age:
55 Years
Study:
NCT06826859
Study Brief:
Protocol Section:
NCT06826859